Using LIMS to solve key laboratory challenges
On-Demand Presentation
Regulatory expectations for your HCP analysis: meet USP <1132.1> to enhance the quality of MS-based data
25 February 2026 | Incl. panellist from U.S. Pharmacopeia (USP)
Opportunities and challenges from ICH Q2 (2) and Q14 for the analytical lifecycle
25 March 2026 | With experts from GSK
Moving HCP LC-MS analysis into a GMP environment
15 April 2026 | Learn directly from Alphalyse's CEO
Advanced ELISA-MS™ for Host Cell Protein (HCP) coverage and ELISA Antibody Characterisation
17 June 2026
Beyond Sample Tracking – LIMS as the Backbone of Laboratory Data Integrity
On-Demand Presentation by Ramon de Groot (Limes Lab Support)
Translating small-molecule development to complex generics and biosimilars
On-Demand Presentation by Dr. Joseph Glajch (JLG AP Consulting)
An Overview of Key Differences of the CMC Processes in Small-Molecule Drugs and Biotherapeutics
On-Demand Presentation by by Dr Michael Dong (MWD Consulting)
Understanding the Differences Between Small-Molecule Drugs and Biotherapeutics: An Overview
On-Demand Presentation by Dr. Michael Dong (MWD Consulting)
Synthetic-Biologics Fusion Cuisine: Innovation in Analytical Characterisation of Novel Drug Modalities
On-Demand Presentation by Dr. Bingchuan Wei, MBA (Genentech)
Advertisement
Advertisement
Advertisement